ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has completed an IPO in the amount of HKD 318.93792 million.

Security Name: H Shares
Security Type: Common Stock
Securities Offered: 1,714,800
PriceRange: HKD 18.6
Discount Per Security: HKD 0.744

Security Name: H Shares
Security Type: Common Stock
Securities Offered: 12,485,200
PriceRange: HKD 18.6
Discount Per Security: HKD 0.744

Security Name: H Shares
Security Type: Common Stock
Securities Offered: 2,947,200
PriceRange: HKD 18.6
Discount Per Security: HKD 0.744

Transaction Features: Regulation S; Rule 144A; Sponsor Backed Offering